Glaxo Agrees To Settle Paxil Litigation For $63.8M
GlaxoSmithKline PLC is dishing out $63.8 million to settle claims in a class action lawsuit that it marketed its antidepressant drug Paxil to kids and teenagers while hiding information about the...To view the full article, register now.
Already a subscriber? Click here to view full article